comprehensive -WSS

comprehensive

author：knowledge 2025-09-07 11:16:16 - browse：77

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： PBM reforms clear House panel

focus

WSS

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Oak Street deal isn't the answer to health care's woes

What a koala virus tells us about the human genome

Astellas still sees hope in its gene therapy after four deaths

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

focus

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

The high cost of giving birth even with insurance

As H5N1 spreads in cows, experts warn against drinking raw milk

At least 13 dead in Texas as scorching temps continue

Congress must reauthorize a committee to support older Americans

New air purifier tech could be key to improving indoor air quality

Hottest summer in 2,000 years puts focus on extreme heat, health

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Wikipedia

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

In key trial, Verve's treatment lowers cholesterol levels in patients

Hospitals look to new technology to keep health care workers safe

FDA's Woodcock to retire early next year

STAT reporters are Pulitzer Prize finalists for investigative reporting

leisure time

focus

Wikipedia

hotspot